Skip to main content
. Author manuscript; available in PMC: 2018 Jan 15.
Published in final edited form as: Virology. 2016 Nov 23;501:88–91. doi: 10.1016/j.virol.2016.11.004

Table 2.

Neutralization assays for the highest and lowest HI titer samples.

Farm IDa Sample IDb HI titerc
NI titer d
D/13N D/46N D/46N
J5(10) 150 640 640 80
104 10 20 20
J6(10) 51 320 160 160
110 20 20 10
J7(6) 23 320 160 40
177 10 20 10
J8(6) 169 160 320 80
30 <10 10 10
J9(6) 28 160 160 40
1 10 20 10
J10(8) 229 320 320 160
116 <10 <10 <10
J14(10) 85 320 320 160
33 20 20 10
J17(10) 52 320 320 320
94 <10 <10 <10
J18(10) 311 320 320 160
127 160 160 80
J19(8) 156 640 640 160
85 20 20 <10
J20(8) 143 640 320 160
64 160 160 80
J23(7) 129 320 320 80
71 40 40 <10
J25(10) 2 1280 640 320
119 <10 <10 <10
J26(10) 98 640 640 160
110 <10 <10 <10
J28(7) 116 320 320 80
117 20 20 10
J31(10) 230 160 320 80
217 <10 <10 20
J33(5) 128 80 320 80
6 20 20 20
J34(10) 136 320 320 320
179 <10 <10 <10
J35(10) 110 640 320 80
59 <10 20 10
J36(10) 93 160 320 160
26 <10 <10 <10
J37(8) 93 320 320 80
122 <10 <10 <10
J38(10) 76 320 320 80
26 20 40 <10
J39(5) 7 160 320 160
11 10 20 20
J45(4) 70 160 320 160
71 40 80 10
J48(9) 208 320 320 160
180 40 40 20
J54(7) 275 640 640 160
92 20 10 <10
J55(6) 39 640 640 160
26 <10 <10 <10
J56(5) 19 160 320 80
97 20 20 10
J57(7) 140 320 320 80
23 <10 <10 <10
J60(6) 27 320 640 160
55 10 20 <10
J62(8) 5 640 640 320
33 40 80 20
J63(5) 133 640 640 80
130 40 40 20
J64(6) 14 640 640 320
101 10 20 20
J66(5) 316 320 320 80
278 10 20 20
J67(6) 110 320 320 320
88 80 160 160
J68(5) 9 640 640 160
133 10 20 10
J69(5) 26 640 640 80
28 20 20 20
J70(5) 82 320 640 160
96 <10 <10 <10
J71(5) 72 640 640 320
15 80 160 40
J72(5) 95 320 320 160
274 <10 <10 <10

Note:

a

The 46 farms listed were selected randomly from 73 farms in Nebraska;

b

Two samples with the highest and lowest HI titers were selected for neutralization inhibition assays;

c

HI assays were performed against two prototype viruses D/13N and D/46N using 0.5% turkey red blood cells;

d

NI assays were performed in human rectal tumor (HRT-18G) cells against the prototype virus D/46N.